(626) 355-2053 (626) 836-9149 info@zeta-corp.com
Distributor Login
    Awareness Month of Prostate Cancer
    September
    NEW PRODUCT FOCUS
    Spring 2024
    Catalog Updated
    August 24,2024
    Four New Products
    September, 2023
    MMR related antibodies
    DNA mismatch repair (MMR) system
    CEACAM5 rabbit monoclonal antibody
    Clone ZR370
    Welcome Dr. Cheri Walker
    IVD Antibodies
    Zeta develops highly specific and sensitive primary recombinant and monocloncal antibodies for immunohistochemistry suitable for routine and differential diagnosis in anatomic pathology laboratories. The large portfolio of recombinant antibodies includes 370+ tumor and tissue specific IVD recombinant antibodies for immunohistochemistry.
    MonoMAb™
    MonoMAb™ mouse monoclonal antibodies are uniquely developed monospecific antibodies where high performing clones are screened using a high throughput protein chip to select the most specific one. Finally, they are sequenced and engineered for recombinant production providing the most rapid, reliable and reproducible manufacturing.
    RAbMono™
    RAbMono™ rabbit monoclonal antibodies are uniquely produced and target-validated for IHC on FFPE tissue sections. They stand out because of their superior specificity, low background, and high affinity. Finally, they are sequenced and engineered for recombinant production providing the most rapid, reliable and reproducible manufacturing.

    About
    Corporation

    Zeta Corporation is leader in IVD precision recombinant antibodies for immunohistochemistry.  Zeta is an ISO 13485:2016 and FDA registered biomedical company that manufactures and distributes IVD antibodies for Pathology/IHC. We provide the highest quality of antibodies to help pathologists diagnose human tumors and diseases.  Zeta antibodies are carefully curated to provide reproducible results on formalin-fixed, paraffin-embedded (FFPE) sections manually or using commercially available automated equipment.  Zeta utilizes its collective knowledge of over 75 years to validate and standardize every antibody individually for immunohistochemistry (IHC) application.

    We are proud of our commitment to producing highly specific, target-validated, and characterized IVD primary biomarkers to aid pathologists in the differential diagnosis of various tumors.

    Zeta Corporation sells the products directly in the US and distributes them to over 50 different countries globally through our trusted partners.

     

    Learn more about Zeta Corporation
    Request More Information
    CONTACT US